Affidea is the leading, pan-European medical service provider, specialising in diagnostics investigations, clinical laboratories and cancer treatment services.

Operating a highly respected portfolio of over 140 medical centers across the continent, Affidea’s services are at the cutting edge of patient care. Having already been the majority investor in the company, Waypoint completed the acquisition of Affidea in 2014.